Procainamide-induced lupus lung disease characterized by neutrophil alveolitis.
Bronchoalveolar lavage demonstrated a flux of neutrophils into the lung of a patient with procainamide-induced lupus pulmonary disease. Serial lavage studies have shown persistent low-grade alveolitis despite the absence of clinical, serologic, and radiographic evidence of disease activity.
D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000473:pathology*; D011014:Pneumonia / Q000139:chemically induced* / Q000175:diagnosis; D011342:Procainamide / Q000009:adverse effects*; D011650:Pulmonary Alveoli / Q000473:pathology
D011342:Procainamide